AI Terminal
Nicox S.A.
Regulatory Filings • Jul 5, 2022
1556_iss_2022-07-05_b9c16e2d-4331-4dbf-9014-cb104ec5fdad.pdf
Regulatory Filings
Open in ViewerOpens in native device viewer
Press Release
Nicox: Half-year liquidity contract statement for NICOX
July 5, 2022 – release at 7:30 am CET Sophia Antipolis, France
Under the liquidity contract entered into between NICOX and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th , 2022:
- 233,609 shares
- € 106,207.47
- Number of executions on buy side on semester: 526
- Number of executions on sell side on semester: 571
- Traded volume on buy side on semester: 336,531 shares for € 706,259.94
- Traded volume on sell side on semester: 314,889 shares for € 660,405.27
As a reminder :
- the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:
- 211,967 shares
- € 152,371.09
- Number of executions on buy side on semester: 786
- Number of executions on sell side on semester: 728
- Traded volume on buy side on semester: 387,737 shares for € 1,278,136.61
- Traded volume on sell side on semester: 394,689 shares for € 1,304,467.12
- the following resources appeared on the liquidity account when the activity started:
- 0 shares
- € 500,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
| Buy Side | Bell Sicie | |||||
|---|---|---|---|---|---|---|
| Number of executions |
Number of charac |
Traded volume In Euro |
Number of expourilions |
Number of charac |
Traded volume In EUR |
|
| Total | 538 | 338 624 | 708,269.84 | ક્રન | 314,888 | 680,406.27 |
| 03/01/2022 | 17 | 0000 | 21,040.00 | |||
| 04/01/2022 | 4 | 4,000 | 10,360.00 | 9 | 4,000 | 10,600.00 |
| 05/01/2022 | = | 22 | 22,000 | 60,720.00 | ||
| 08/01/2022 | 1 | 1 | 277 | 1 | = | |
| 07/01/2022 | 13 | 9,000 | 24,750.00 | |||
| 10/01/2022 | 4 | 4,000 | 10,880.00 | 3 | 2,000 | 5,800.00 |
| 1101/2022 | 7 | 3,137 | 8,695.38 | |||
| 12/01/2022 | 4 | 2,000 | 5,500.00 | 10 | 3,883 | 10,739.14 |
| 13/01/2022 | 8 | 2,000 | 00 0999 EP | = | = | |
| 14/01/2022 | 16 | 2,000 | 13,650.00 | 1 | 13 | 36.14 |
| 17/01/2022 | 10 | 2,000 | 2,500.00 | |||
| 18/01/2022 | 3 | 3,000 | 8,160.00 | |||
| 19/01/2022 | 3 | 5,000 | 13,500.00 | |||
| 2010 1/2022 | N | 0000'E | 0000000 | 1 | 1 | 272 |
| 2101/2022 | 10 | 10,277 | 27,234.05 | |||
| 24/01/2022 | 34 | 20,000 | 50,600.00 | 1 | ||
| 250112022 | 0 | 3 easy | 8,692.43 | |||
| 26/01/2022 | 0 | 5,000 | 11,750.00 | 1 | ||
| 27/01/2022 | 4 | 3,000 | 6,960.00 | = | ||
| 2810 112022 | 3 | 2,000 | 4,600.00 | |||
| 3101/2022 | 5 | 2,000 | 4,620.00 | |||
| 01022022 | 7 | 5,000 | 11,400.00 | 5 | 4,000 | a 330.00 |
| 02/02/2022 | 18 | 12,050 | 28,197.00 | |||
| 03/02/2022 | 10 | 6,745 | 15,613.50 | 3 | 1,951 | 4,584.85 |
| 04/02/2022 | 12 | 1,255 | 16,178.65 | 1 | 1 | 233 |
| 07/02/2022 | 3 | 2,000 | 4,400.00 | 2 | 2,000 | 4,500.00 |
| 08/02/2018072 | 1 | 1,000 | 2,180.00 | 13 | 13,745 | 31,888.40 |
| ORIOZOZOZOFICI | 1 | 1,000 | 2,180.00 | = | = | |
| 100272022 | 14 | 6,000 | 12,960.00 | 1 | DOG | 1,980.00 |
| 110202022 | 6 | 3,000 | 6,420.00 | 6 | 4,000 | 8,640.00 |
| 14/02/2022 | 8 | 5,000 | 10,450.00 | |||
| 150/02/20122 | = | 28 | 14,350 | 30,665,50 | ||
| 16/02/2022 | 2 | 1,000 | 2,140.00 | g | റ, വാഗ | 12,852,00 |
| 17/02/2022 | 8 | 00078 | 16,720.00 | 1 | ||
| 18/02/2022 | 7 | 3,000 | 6,090.00 | = | ||
| 23 17:74 102 | 5 | 4,000 | 8,400.00 | 22 | 17,101 | 36,596,14 |
| 24 Lazon 2 | 14 | 0,000 | 12,120.00 | |||
| 25/02/2022 | Ch | 7,000 | 14,490.00 | |||
| 28/02/2022 | 2 | 1 2023 | 3,199.18 | 11 | 4,044 | 8,573.28 |
| 0103/2022 | 8 | 8,446 | 17,652.14 | 14 | 8,023 | 17,313.95 |
| UZUZIZOZZOZZ | 7 | 2000 | 10,400.00 | 1 | 1 | 2.15 |
| US UST 2007 | 14 | alooo | 18,380.00 | 8 | ll | |
| 04/03/2022 | 14 | 10,000 | 19,400.00 | = | ||
| 07/03/2022 | 7 | 3,000 | 5,670.00 | |||
| 08/03/2022 | 5 | 3,500 | 6,300.00 | 0 | 3,000 | 5,520.00 |
| 09/03/20180/12/2017/09/2019 | 12 | 20,000 | 37,529.03 | |||
| 1003/2002 | = | 11 | 10,051 | 19,297.92 | ||
| 1103/2022 | = | 14 | 0,045 | 17,637.75 | ||
| 14/03/2022 | 1 | 744 | 1,602.88 | 5 | 4,000 | 0000000 |
| 150312022 | 12 | 7,256 | 14,149.20 | |||
| 16/03/2022 | 1 | 1,000 | 1,980.00 | 9 | 6,000 | 12,000.00 |
| Buy Side | Bell Sicie | |||||
|---|---|---|---|---|---|---|
| Number of executions |
Number of charac |
Traded volume in Euro |
Number of expourilions |
Number of charac |
Traded volume In EUR |
|
| Total | 1200 | 338 624 | 708,269.84 | 671 | 314,839 | 880,406.27 |
| 17/03/2022 | 2 | 2,000 | 3,940.00 | |||
| 18/03/2022 | 5 | 4,000 | 0000000 | |||
| 2103/2022 | 5 | 3,602 | 7,348.08 | |||
| 220352022 | 5 | 2,388 | 5,083.76 | |||
| 23/03/2022 | 5 | 2,000 | 4,020.00 | |||
| 24/03/2022 | 1 | 1,000 | 1,980.00 | |||
| 25/03/2022 | 2 | 2,000 | 3,900.00 | |||
| 28/03/2022 | 11 | 6,000 | 11,760.00 | 6 | 6,000 | 12.540.00 |
| 29/03/2022 | 10 | 7,044 | 13,876.68 | 14 | 9,000 | 18,090,00 |
| 3003/2022 | 3 | 2,000 | 3,940.00 | 2 | 2,000 | 4,020.00 |
| 3103/2022 | 0 | 3,000 | 0000000 | |||
| 01/04/2022 | 2 | 1,000 | 3,839.55 | 2 | 1,000 | 1,980.00 |
| 04/04/2022 | 3 | 2,000 | 0000000 | 1 | 15 | 29.85 |
| 05/04/2022 | 1 | 1,000 | 1,960.00 | 3 | 1,886 | 3,910.45 |
| 08/04/2022 | 16 | 6,103 | 11,595.70 | |||
| 07/04/2022 | 11 | 11,000 | 20,130.00 | 13 | 7,000 | 13,440.00 |
| 08/04/2022 | 11 | 9,000 | 15,480.00 | 0 | 2,000 | 3,600.00 |
| 1104/2022 | 5 | 4,000 | e legger do | 17 | 11,000 | 19,470.00 |
| 12/04/2022 | 7 | 4,000 | 6,880.00 | 7 | 6,000 | 10,500.00 |
| 13/04/2022 | 0 | 2,000 | 3,540.00 | |||
| 14/04/2022 | 0 | 4,000 | 7,000.00 | |||
| 1904/2022 | 3 | 2,000 | 3,420.00 | 1 | 1,000 | 1,720.00 |
| 20/04/2022 | NJ | 2,000 | 3,420.00 | |||
| 2104/2022 | 1 | 1,000 | 1,720.00 | |||
| 2204/2022 | 1 | 1,000 | 1,680.00 | 3 | 1,001 | 1,741.74 |
| 25/04/2022 | 3 | 2,000 | 3,340.00 | 2 | 1,000 | 1,680.00 |
| 26/04/2022 | ப் | 2,000 | 3,340.00 | 1 | 1,000 | 1,700.00 |
| 27104/2022 | 1 | 1,000 | 1,660.00 | - | ||
| 28/04/2022 | 9 | 3,877 | 6,629.67 | |||
| 2904/2022 | 1 | 1 | 1.74 | |||
| 02/05/2022 | 5 | 2,121 | 3,711.75 | |||
| 03/05/2022 | 18 | 8,014 | 14,585.48 | |||
| 04/05/2022 | 4 | 2,200 | 4,004.00 | 2 | 1200 | 972.40 |
| 05/05/2022 | 5 | 1,800 | 3,222.00 | 1 | 1 | 1.85 |
| 06/05/2022 | 5 | 3,013 | 5,272.75 | 3 | 3,001 | 5,431.81 |
| 09/05/2022 | 1 | 1,000 | 1,800.00 | 3 | 1,989 | 3,658 17 |
| 10/05/2022 | 4 | 2,038 | 5,317.78 | 1 | 1,000 | 1,860.00 |
| 1105/2022 | 10 | 3,062 | 5,480.98 | |||
| 1205/2022 | 4 | 3,5687 | 6,817.77 | 2 | 2 | 3.50 |
| 13/05/2022 | 8 | 1,989 | 3,458.27 | |||
| 16/05/2022 | 4 | 1 ଅଟେ । ସେଥି | 3,538.23 | |||
| 17/05/2022 | 1 | 1 | 1.80 | |||
| 18/05/2022 | B | 4 | 2,989 | 5,458 18 | ||
| 19/05/2022 | 5 | 3,000 | 5,460.00 | |||
| 20105/2022 | 1 | 115 | 209,30 | 7 | 4,000 | 7,440.00 |
| 23/05/2022 | NJ | 1,000 | 1,840.00 | 2 | 1,000 | 1,880.00 |
| 24/05/2022 | 9 | 4,007 | 8,881.67 | |||
| 2007/2002 | 4 | 1,978 | 3,501.06 | 1 | 50 | 000000 |
| 26/05/2022 | 4 | 2,000 | 3,500.00 | 67 | 1,001 | 1,781.78 |
| 27/05/2022 | 4 | 3,949 | 7,187.18 | |||
| 30/05/2022 | 5 | B80 | 1,619.20 | 3 | 2,000 | 3,700.00 |
| Buy Side | Sell Side | |||||
|---|---|---|---|---|---|---|
| Number of excoultions |
Number of Charac |
Tiraded volume in Burt |
Humber of expendons |
Number of ទោย |
Traded volume In EUR |
|
| Total | 1999 | 338.651 | 708,269,84 | KH | 314,239 | 680,406,89 |
| 31093002 | E | 5.120 | 9,164,80 | 1 | First | 1,616,40 |
| 0110972027 | = | = | 3 | 1,000 | 1.780.00 | |
| 02005/2022 | - | - | 2 | 102 | 183.60 | |
| 11-01-12-02-2 | = | = | T | 2,000 | 5,830,00 | |
| 0-05-05-2 | T | 1000 | 1,820,00 | 2 | 201 | 373 85 |
| 0700964072 | 1 | 1.000 | 1.810.00 | |||
| 11-12-12-12-2 | = | 5 | 2179 | 5,200,14 | ||
| 0-05-2022 | 1 | 1.000 | 1,840,00 | |||
| 1000-02022 | 1 | 1000 | 1,820,00 | = | ||
| 1200 mirr | 8 | C Citi | 10,560.00 | T | 1,000 | 1.760.00 |
| 1405 2007 | 2000 | 3,460,00 | 2 | 1.050 | 1.869.00 | |
| 1505/4177 | F | 1,000 | 1,760,00 | 1 | 1 | 1.78 |
| 160-12007 | 3 | 2.000 | 5.160.00 | 2 | 1.000 | 1.780.00 |
| 2005/2017 | 5 | 2.160 | 3.780.00 | |||
| 2100 Park 2 | = | = | B | 2 17:00 | 5,020,20 | |
| 220-12-17-2 | 7 | 1000 | 1.780.00 | = | - | |
| 2200 Fact 2 | 3 | 2.000 | 5.370.00 | 2 | 1,000 | 1,841,84 |
| 2400 12002 | 7 | 90 | 162.00 | = | ||
| 2700 Guar | = | = | 5 | 1,450 | 2653.50 | |
| 2800 12002 | 1 | 1 | 1 88 | 2 | FILT | 1.017.50 |
| 2000 12002 | 2 | 111 | 1 639.90 | 1 | 59 | F2.08 |
| BIND FARE ? | 12 | 6.999 | 12.248.25 |
About Nicox
Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Nicox's lead program in clinical development is NCX 470, a novel nitric oxide-donating prostaglandin analog, for lowering intraocular pressure in patients with glaucoma. The company is also developing NCX 4251, a proprietary formulation of fluticasone propionate, for dry eye disease. Nicox generates revenue from VYZULTA® in glaucoma, licensed exclusively worldwide to Bausch + Lomb, and ZERVIATE® in allergic conjunctivitis, licensed in multiple geographies, including to Eyevance Pharmaceuticals, LLC, in the U.S. and Ocumension Therapeutics in the Chinese and in the majority of Southeast Asian markets.
Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.
For more information on Nicox, its products or pipeline, please visit: www.nicox.com.
Analyst coverage
| Bryan, Garnier & Co | Dylan van Haaften | Paris, France |
|---|---|---|
| Edison Investment Research | Pooya Hemami | London, UK |
| H.C. Wainwright & Co | Yi Chen | New York, U.S. |
| Kepler Cheuvreux | Arsene Guekam | Paris, France |
The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports.
Contacts
Nicox
Gavin Spencer Executive Vice President, Chief Business Officer & Head of Corporate Development T +33 (0)4 97 24 53 00 [email protected]
Investors & Media
United States & Europe LifeSci Advisors, LLC Sandya von der Weid T +41 78 680 05 38 [email protected]
Forward-Looking Statements
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.
Risks factors which are likely to have a material effect on Nicox's business are presented in the 3rd chapter of the 'Document d'enregistrement universel, rapport financier annuel et rapport de gestion 2021' filed with the French Autorité des Marchés Financiers (AMF) on April 29, 2022 which is available on Nicox's website (www.nicox.com).
Nicox S.A.
Drakkar 2 Bât D, 2405 route des Dolines CS 10313, Sophia Antipolis 06560 Valbonne, France T +33 (0)4 97 24 53 00 F +33 (0)4 97 24 53 99